4,5-Difluoro-2-methylbenzonitrile
Names and Identifiers of 4,5-Difluoro-2-methylbenzonitrile
CAS Number |
1003708-82-4 |
|---|---|
MDL Number |
MFCD09996935 |
IUPAC Name |
4,5-difluoro-2-methylbenzonitrile |
InChI |
InChI=1S/C8H5F2N/c1-5-2-7(9)8(10)3-6(5)4-11/h2-3H,1H3 |
InChIKey |
NEUWJWYFYDQUMY-UHFFFAOYSA-N |
Canonical SMILES |
CC1=CC(=C(C=C1C#N)F)F |
UNSPSC Code |
12352100 |
Physical and chemical properties of 4,5-Difluoro-2-methylbenzonitrile
Boiling Point |
214.3±35.0 °C at 760 mmHg |
|---|---|
Density |
1.2±0.1 g/cm3 |
Exact Mass |
153.039001 |
Flash Point |
83.4±25.9 °C |
Index of Refraction |
1.487 |
LogP |
1.88 |
Molecular Formula |
C8H5F2N |
Molecular Weight |
153.129 |
PSA |
23.79000 |
Storage condition |
Sealed in dry,Room Temperature |
Vapour Pressure |
0.2±0.4 mmHg at 25°C |
Safety Information of 4,5-Difluoro-2-methylbenzonitrile
Applications of 4,5-Difluoro-2-methylbenzonitrile
4,5-Difluoro-2-methylbenzonitrile finds applications in several domains:
- Pharmaceuticals: As an intermediate in the synthesis of active pharmaceutical ingredients (APIs) like trelagliptin.
- Materials Science: Utilized as a building block in the development of thermally activated delayed fluorescence (TADF) emitters for organic light-emitting diodes (OLEDs) due to its favorable optoelectronic properties.
- Chemical Research: Employed in synthetic organic chemistry as a versatile reagent for creating complex molecules.
Interaction Studies of 4,5-Difluoro-2-methylbenzonitrile
Interaction studies involving 4,5-difluoro-2-methylbenzonitrile have shown that it can act as a substrate for various enzymes and receptors. Its structural features allow it to interact effectively with biological macromolecules, which is crucial for drug design and development. Studies indicate that its derivatives may inhibit specific cytochrome P450 enzymes, influencing drug metabolism and pharmacokinetics.
Biological Activity of 4,5-Difluoro-2-methylbenzonitrile
Research indicates that 4,5-difluoro-2-methylbenzonitrile and its derivatives exhibit significant biological activity. For instance, its analogs have been explored for their potential as anti-diabetic agents. The compound serves as an intermediate in the synthesis of trelagliptin succinate, a medication used in managing type II diabetes mellitus. Its structural characteristics may contribute to favorable interactions with biological targets.
Physical sample testing spectrum (NMR) of 4,5-Difluoro-2-methylbenzonitrile
